We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$83.2B
AUM Growth
+$1.08B
Cap. Flow
-$819M
Cap. Flow %
-0.99%
Top 10 Hldgs %
34.54%
Holding
3,151
New
709
Increased
920
Reduced
837
Closed
626

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.06B
2
UNH icon
UnitedHealth
UNH
+$935M
3
UBER icon
Uber
UBER
+$426M
4
BA icon
Boeing
BA
+$312M
5
CRM icon
Salesforce
CRM
+$309M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Consumer Discretionary 14.92%
3 Healthcare 12.54%
4 Financials 8.46%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NINE
2351
DELISTED
Nine Energy Service
NINE
$168K ﹤0.01%
+150,167
New +$177K
NEOV icon
2352
NeoVolta
NEOV
$120M
$167K ﹤0.01%
+32,132
New +$135K
SNDX icon
2353
Syndax Pharmaceuticals
SNDX
$1.82B
$167K ﹤0.01%
12,624
-977,280
-99% -$16.7M
BBCP icon
2354
Concrete Pumping Holdings
BBCP
$522M
$166K ﹤0.01%
24,993
+1,529
+7% +$9.41K
HLLY.WS
2355
CALL
DELISTED
Holley Inc Warrants
HLLY.WS
$166K ﹤0.01%
55,000
-55,000
-50% -$2.7K
ADT icon
2356
ADT
ADT
$5.24B
$166K ﹤0.01%
24,000
-9,785
-29% -$71.3K
TALO icon
2357
Talos Energy
TALO
$2.36B
$164K ﹤0.01%
+16,884
New +$178K
LX
2358
LexinFintech Holdings
LX
$241M
$163K ﹤0.01%
28,074
-34,426
-55% -$145K
CTNM
2359
Contineum Therapeutics
CTNM
$518M
$159K ﹤0.01%
+10,836
New +$172K
PRQR icon
2360
ProQR Therapeutics
PRQR
$244M
$158K ﹤0.01%
+59,515
New +$189K
CFFN icon
2361
Capitol Federal Financial
CFFN
$1.07B
$156K ﹤0.01%
26,465
-270,211
-91% -$1.72M
SGHC icon
2362
SGHC Ltd
SGHC
$7.45B
$156K ﹤0.01%
+25,100
New +$134K
MHH icon
2363
Mastech Digital
MHH
$93.1M
$156K ﹤0.01%
+10,485
New +$130K
AVD icon
2364
American Vanguard Corp
AVD
$75.2M
$155K ﹤0.01%
33,584
-51,532
-61% -$279K
C icon
2365
CALL
Citigroup
C
$223B
$155K ﹤0.01%
+2,200
New +$148K
AMPX icon
2366
Amprius Technologies
AMPX
$1.38B
$150K ﹤0.01%
+53,635
New +$93.7K
ATEK.WS
2367
CALL
DELISTED
Athena Technology Acquisition Corp. II Redeemable Warrants
ATEK.WS
$150K ﹤0.01%
150,000
-13,584
-8% -$505
EQX icon
2368
Equinox Gold
EQX
$7.51B
$149K ﹤0.01%
29,740
+13,004
+78% +$72.7K
AERTW
2369
CALL
Aeries Technology Warrant
AERTW
$149K ﹤0.01%
160,000
FRST icon
2370
Primis Financial Corp
FRST
$393M
$148K ﹤0.01%
+12,714
New +$153K
NVNO
2371
enVVeno Medical
NVNO
$7.12M
$147K ﹤0.01%
+1,395
New +$156K
FXE icon
2372
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$341M
$143K ﹤0.01%
+1,500
New +$148K
EPM icon
2373
Evolution Petroleum
EPM
$129M
$143K ﹤0.01%
+27,249
New +$149K
STGW icon
2374
Stagwell
STGW
$1.92B
$141K ﹤0.01%
+21,500
New +$153K
AMPY icon
2375
Amplify Energy
AMPY
$155M
$141K ﹤0.01%
+23,469
New +$154K

Similar funds

Marshall Wace's Q4 2024 Portfolio in Review

As of Q4 2024, Marshall Wace held 3,151 positions worth $83.2B, up 1.3% from $82.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace's Q4 2024 filing shows 709 new, 920 increased, 837 reduced and 626 closed positions. Its largest new stake was Boeing: 1,988,038 shares worth $352M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.09B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q4 2024 buy was Boeing: 1,988,038 shares worth $352M.
  • Marshall Wace added most to Apple in Q4 2024, an estimated $1.06B increase.
  • Marshall Wace's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
  • Marshall Wace fully exited GE Vernova in Q4 2024, selling an estimated $439M.
  • Marshall Wace's ten largest holdings make up 35% of its $83.2B portfolio in Q4 2024.
  • Marshall Wace opened 709 new positions and closed 626 in Q4 2024.
  • Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $83.2B.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.